Search alternatives:
lines » line (Expand Search)
Showing 421 - 440 results of 509 for search '(((((( peer decrease ) OR ( lines increase ))) OR ( ftir decrease ))) OR ( mean decrease ))', query time: 0.16s Refine Results
  1. 421
  2. 422
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432

    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 by Stein Emil, Vollset

    Published 2024
    “…In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5–17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7–11·3) in the high-income super-region to 23·9% (20·7–27·3) in north Africa and the Middle East. …”
    Get full text
    Get full text
    Get full text
    article
  13. 433

    Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2... by Michael, Brauer

    Published 2024
    “…Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2·5th and 97·5th percentile values across the draws. …”
    Get full text
    Get full text
    Get full text
    article
  14. 434
  15. 435

    Machine Learning Models for Scheduling On-Demand Fog Placement and Optimizing Container Deployment by Farhat, Peter

    Published 2020
    “…Second, we propose a K-Means based clustering model embedded within a multi-objective optimization scheme for fog and container placement. …”
    Get full text
    Get full text
    Get full text
    masterThesis
  16. 436

    The Contribution of the UAE School Inspection Framework as a Quality Assurance Tool for School Transformation and Performance Improvement by EL SAADI, DINA HUSSEIN

    Published 2017
    “…It is recommended that American schools in Dubai must fine-tune global school transformation elements in line with school performance indicators so as to remain globally competitive in an increasingly globalized world.…”
    Get full text
  17. 437

    Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro by Najem, Sonia A.

    Published 2019
    “…Objective: In this study, we evaluated the effect of Suberoylanilide Hydroxamic Acid (SAHA), a panhistone deacetylase inhibitor, and Decitabine (DAC), a DNA methyltransferase inhibitor, either alone or in combination, on Caco-2 human colon cancer cell line in vitro. Results: Our results showed that SAHA and DAC, separately, significantly decreased cell proliferation, induced apoptosis and cell cycle arrest of Caco-2 cell line. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  18. 438

    Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer by El-Amm, Joelle

    Published 2017
    “…Abiraterone acetate has established a major role in the treatment paradigm of metastatic castration-resistant prostate cancer ever since pivotal trials, COU-AA-301 and COU-AA-302, have shown benefit in both the second-line and first-line (post- and pre-chemotherapy) setting, respectively, with improvement in overall survival as well as secondary end points such as prostate-specific antigen (PSA) and radiographic response rates, time to PSA progression, and progression-free survival. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  19. 439
  20. 440

    Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report by Maysaloun Merhi (4246147)

    Published 2018
    “…His NY-ESO-1 antibody was found to be lower after the third (****p < 0.0001) and the fifth (****p < 0.0001) cycles of treatment compared to base line, and this was in line with the stability of the disease. …”